SOLANA BEACH, Calif. - Artelo Biosciences , Inc. (NASDAQ:ARTL), a clinical-stage biopharmaceutical company with a market capitalization of $4.5 million, announced nonclinical results for its ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...

Artelo Biosciences (ARTL) announced nonclinical results on ART12.11, its proprietary cocrystal composition of cannabidiol and ...

Analysts have set 12-month price targets for Jazz Pharmaceuticals, revealing an average target of $181.11, a high estimate of ...

Global pharma company Jazz Pharmaceuticals has ended patent claims related to its cannabinoid-based epilepsy drug, Epidiolex.

The success of Epidiolex prompted several companies to attempt to create generic versions. Jazz Pharmaceuticals plc (NASDAQ: ...

KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW), a drug delivery platform innovator with a market capitalization of $29.84 million, has announced the issuance of two new patents by ...

Additions broaden DehydraTECH patent suite for Epilepsy KELOWNA, BC / ACCESS Newswire / February 11, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

In FY24, India had added around 6 GW of thermal units. So far in the fiscal year, two thermal units with a total capacity of 1,320 MW have been commissioned, that too in December. The rest are ...

For instance, GW Pharma stated in February 2024 that ... for the highest revenue-grossing segment in the global cannabis pharmaceuticals market in 2023 and is predicted to grow at the fastest ...

Acme Solar Holdings is actively seeking 1 GW renewable energy projects with land and grid connectivity to expand its portfolio rapidly. The company, with 2.5 GW operational and 4.4 GW under ...